| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/15/2008 | US20080113973 Pharmaceutical composition in unit dose form which contains a COX-2 inhibitor and a thromboxane A2 receptor antagonist; for treatment of pain or inflammation; less risk of inducing adverse cardiovascular effects than when COX-2 inhibitors are administered alone |
| 05/15/2008 | US20080113972 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis |
| 05/15/2008 | US20080113960 Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113949 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin II antagonist for stroke prevention |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113916 Povidone-Containing Carriers for Polypeptide Growth Factors |
| 05/15/2008 | US20080113905 Biologically active peptide with extended half-life and a slower clearance compared to unPEGylated peptide; PEGylated GLP-1 compounds treat diabetes, obesity, irritable bowel syndrome |
| 05/15/2008 | US20080113900 Nutraceutical; reduce serum homocysteine levels; protects cells from damage and death when exposed to oxidative stress conditions; human food supplements, multivitamin preparations, breakfast foods, infant formulas, complete diet and weight-loss formulas and bars |
| 05/15/2008 | US20080113896 Nutraceutical, medicament; peptides isoleucine-proline-proline and valine-proline-proline from casein; dietary supplement or a personal care application; topical lotion, gel; emulsion, food, beverage, feed or pet food ingredient |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | US20080112997 Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo |
| 05/15/2008 | US20080112930 Stent coated with sarcoplasmic reticulum calcium ATPase (SERCA) nucleotide sequences for use in treatment and prevention of vascular constriction |
| 05/15/2008 | US20080112919 Tnp-470 polymer conjugates and use thereof |
| 05/15/2008 | CA2702645A1 Process for the preparation of angiogenin |
| 05/15/2008 | CA2669166A1 Use of an adenosine antagonist |
| 05/15/2008 | CA2667682A1 Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
| 05/15/2008 | CA2665073A1 Salt of aliskiren with orotic acid |
| 05/14/2008 | EP1921133A2 System for processing lipoaspirate cells |
| 05/14/2008 | EP1921085A1 Therapeutic agent for hypertension |
| 05/14/2008 | EP1921078A1 Multikinase inhibitor |
| 05/14/2008 | EP1921065A1 Phenylpyridone derivative |
| 05/14/2008 | EP1920773A1 Compositions for inhibition of anglogenesis |
| 05/14/2008 | EP1920771A2 Methods of treating hyperlipidemia |
| 05/14/2008 | EP1919870A1 Ep2 receptor agonists for treating glaucoma |
| 05/14/2008 | EP1919486A2 Core 2 glcnac-t inhibitors |
| 05/14/2008 | EP1919469A2 Process for preparing an angiotensin ii receptor antagonist |
| 05/14/2008 | EP1919468A2 Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof |
| 05/14/2008 | EP1919304A1 Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain |
| 05/14/2008 | EP1771425B1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 05/14/2008 | EP1465900B1 Rho-kinase inhibitors |
| 05/14/2008 | EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/14/2008 | EP1309355B1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 05/14/2008 | EP1300158B1 Pharmaceutical compositions for angiogenic therapy |
| 05/14/2008 | EP1278540B1 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 05/14/2008 | EP1242592B1 A molecular switch for regulating mammalian gene expression |
| 05/14/2008 | EP1136083B1 Hgf for gene therapy of cardiomyopathy |
| 05/14/2008 | CN101180276A 2-(phenylamino) benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 05/14/2008 | CN101180046A Stable tablet containing droxidopa |
| 05/14/2008 | CN101177681A Rhabdophis tigrina snake uncoupling protein gene-SB and uses thereof |
| 05/14/2008 | CN101176788A Pharmaceutical composition for ACE restrainer/uretica/folic acid, and uses thereof |
| 05/14/2008 | CN101176772A Pharmaceutical composition made of cattail pollen and safflower |
| 05/14/2008 | CN101176771A Pharmaceutical composition of cattail pollen and pseudo-ginseng |
| 05/14/2008 | CN101176770A Pharmaceutical composition of folium ginkgo and cattail pollen |
| 05/14/2008 | CN101176769A Pharmaceutical composition of cattail pollen and red orpin |
| 05/14/2008 | CN101176751A Pharmaceutical composition of red sage root and cassia twig |
| 05/14/2008 | CN101176747A Application of motherwort aqueous extract in the preparation of medicament for curing ischemic heart disease |
| 05/14/2008 | CN101176743A Chinese medicine for curing coronary disease angina pectoris |
| 05/14/2008 | CN101176740A Method for extracting angelica essential oil |
| 05/14/2008 | CN101176735A Composite preparations for curing schemic brain damage |
| 05/14/2008 | CN101176725A Stabilizer type of simvastatir and aspirin |
| 05/14/2008 | CN101176724A Oxymatrine or matrine sustained-release pellet and preparation method thereof |
| 05/14/2008 | CN101176723A Ranolazine sustained release tablets |
| 05/14/2008 | CN101176720A Ligustrazine microcosmic salt liposome medicine and preparing method |
| 05/14/2008 | CN100387723C Blood vessel growth hormone gene recombined gland relative vrius carrier and its preparation process and application thereof |
| 05/14/2008 | CN100387706C Epothilone -a microtubule stabilizer for treating tumor and blood vessel restenosis |
| 05/14/2008 | CN100387615C Preparation method of N-carboxyalkyl dipeptide type angiotensin converting enzyme inhibitor |
| 05/14/2008 | CN100387587C Process for separating purifying actived tea polyphenols |
| 05/14/2008 | CN100387585C Tanshinone I derivatives and pharmaceutical application thereof |
| 05/14/2008 | CN100387294C Medicine copmosition, its preparing method and quality control method |
| 05/14/2008 | CN100387256C Medicine for treating gastric, anal and intestinal diseases |
| 05/14/2008 | CN100387250C Dripping pills of corydalis tuber |
| 05/14/2008 | CN100387247C Pharmaceutical composition for treating coronary heart disease and ischemia cerebral apoplexy and its preparation method |
| 05/14/2008 | CN100387243C Quality control method of ixeris sonchifolia injection |
| 05/14/2008 | CN100387236C Pharmacetutical for treating cardiovascular and cerebrovascular disease and its preparing process |
| 05/14/2008 | CN100387232C Application of 3-benzyl-5-(2-nitrophenoxymethyl)-gamma-butyrolactone in preparing medicine |
| 05/14/2008 | CN100387229C Amiodarone hydro chloride dispensible tablet, and its preparing method |
| 05/14/2008 | CN100387224C Freeze dried powder injection of hair holly and its preparation process |
| 05/14/2008 | CN100387126C Method of increasing content of flavonoids and phenolic substances in plants |
| 05/13/2008 | US7371896 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 05/13/2008 | US7371895 antiinflammatory agents; autoimmune and cardiovascular disorders; atherosclerosis, rheumatoid arthritis, hyperlipemia; better water solubility increases the bioavailability and pharmacokinetics |
| 05/13/2008 | US7371865 Reacting an organophosphouus compound with metallized alkane; forming atorvastatin, lorastatin, pitavastatin, fluvastatin |
| 05/13/2008 | US7371820 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371810 Tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 05/13/2008 | US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action |
| 05/13/2008 | US7371772 Bicyclic compound, production and use thereof |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371744 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 05/13/2008 | US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability |
| 05/13/2008 | US7371543 Factor VII or VIIa-like molecules |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | US7371382 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders |
| 05/13/2008 | US7371377 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; tissue engineering; bradycardial agents |
| 05/13/2008 | US7371373 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 05/13/2008 | CA2409292C Tablets and methods for modified release of hydrophilic and other active agents |
| 05/13/2008 | CA2327395C New imidazotriazolopyrimidines, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2008 | CA2293470C Benzimidazole derivatives |
| 05/08/2008 | WO2008054795A2 Triazolopyrimidine derivatives as adp p2y12 receptor antagonists |
| 05/08/2008 | WO2008054756A2 Sesquiterpene lactones from artemisia leucodes as anti-inflammatory and gene regulators |
| 05/08/2008 | WO2008054594A2 Method for controlling angiogenesis in animals |
| 05/08/2008 | WO2008054290A1 1h-pyridine- 2 -one derivatives useful in treatment of pai-1 related disorders |
| 05/08/2008 | WO2008053920A1 Physiologically active substance-containing granular composition and method of producing the same |
| 05/08/2008 | WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/08/2008 | WO2008053863A1 Novel compound having 1,4-benzothiazin-3-one skeleton or 3,4-dihydroquinolin-2-one skeleton |
| 05/08/2008 | WO2008053861A1 Novel compound having 1,4-benzoxazin-3-one skeleton |